Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
about
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
description
scientific article published on 14 November 2019
@en
name
Metronomic capecitabine as an ...... eloid-derived suppressor cells
@en
type
label
Metronomic capecitabine as an ...... eloid-derived suppressor cells
@en
prefLabel
Metronomic capecitabine as an ...... eloid-derived suppressor cells
@en
P2093
P1433
P1476
Metronomic capecitabine as an ...... eloid-derived suppressor cells
@en
P2093
Alireza M Mohammadi
Alvaro G Alvarado
Balint Otvos
David M Peereboom
Gustavo Roversi
Harley I Kornblum
Justin D Lathia
Manmeet S Ahluwalia
Mary McGraw
Matthew M Grabowski
P356
10.1172/JCI.INSIGHT.130748
P50
P577
2019-11-14T00:00:00Z